These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6595115)

  • 1. Relative tumour enhancement of 67Ga uptake by desferrioxamine.
    Hammersley PA
    Eur J Nucl Med; 1984; 9(10):461-71. PubMed ID: 6595115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 sarcoma (BALB/c mice).
    Larson SM; Rasey JS; Grunbaum Z; Allen DR
    Radiology; 1979 Jan; 130(1):241-4. PubMed ID: 758657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chelator-induced enhancement of 67Ga tumour imaging: comparison of desferrioxamine with N,N'-ethylene-bis[2-hydroxy-5-carboxyphenylglycine].
    Hunt FC
    Int J Rad Appl Instrum B; 1988; 15(6):651-7. PubMed ID: 3251899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the administration of iron on gallium 67 citrate uptake in tumours.
    Hammersley PA; Taylor DM
    Br J Radiol; 1980 Jun; 53(630):563-71. PubMed ID: 7426867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of distribution of gallium 67 in mouse tumour hosts.
    Sephton RG; De Abrew S; Hodgson GS
    Br J Radiol; 1982 Feb; 55(650):134-41. PubMed ID: 7055660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.
    Koizumi K; Tonami N; Hisada K
    Eur J Nucl Med; 1982; 7(5):229-33. PubMed ID: 6954069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of 67Ga uptake to citrate dose, compared with 67Ga-chloride and 67Ga-transferrin in rodent tissues and tumours.
    Hammersley PA; Zivanovic MA
    Nuklearmedizin; 1980 Feb; 19(1):25-8. PubMed ID: 7402941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of haematoporphyrin derivative on the uptake of 67Ga, 59Fe and 65Zn in tumours.
    Phillips CA; Taylor DM
    Nuklearmedizin; 1978 Dec; 17(6):262-5. PubMed ID: 740543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of ferric citrate on 67Ga-citrate uptake by DS sarcoma tumors.
    Anghileri LJ; Thouvenot P; Brunotte F; Marchal C; Robert J
    Eur J Nucl Med; 1982; 7(6):266-8. PubMed ID: 6955173
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol hydrochloride enhancement of tumor perfusion and uptake of gallium-67 in a mouse sarcoma.
    Bomber P; McCready R; Hammersley P
    J Nucl Med; 1986 Feb; 27(2):243-5. PubMed ID: 3712042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of gallium-67 in transfected cells and tumors absent or enriched in the transferrin receptor.
    Luttropp CA; Jackson JA; Jones BJ; Sohn MH; Lynch RE; Morton KA
    J Nucl Med; 1998 Aug; 39(8):1405-11. PubMed ID: 9708518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of 67Ga uptake in animal and human tumours.
    Hammersley PA; Taylor DM; Cronshaw S
    Eur J Nucl Med; 1980 Oct; 5(5):411-5. PubMed ID: 7215362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of concanavalin A on 67Ga binding by tumor cells.
    Anghileri LJ; Crone-Escanye MC; Robert J
    Nuklearmedizin; 1987 Apr; 26(2):105-7. PubMed ID: 3473448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
    Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
    J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lysosomal enzyme activity in the localization of 67 gallium citrate.
    Hammersley PA; Taylor DM
    Eur J Nucl Med; 1979 Aug; 4(4):261-70. PubMed ID: 499245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desferoxamine mesylate (Desferal): a contrast-enhancing agent for gallium-37 imaging.
    Hoffer PB; Samuel A; Bushberg JT; Thakur M
    Radiology; 1979 Jun; 131(3):775-9. PubMed ID: 441388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biodistribution of 67Ga-labelled N-hydroxyamino acid derivatives in tumour-bearing rats.
    Herscheid JD; Knops GH; Hoekstra M
    Nucl Med Commun; 1986 Jan; 7(1):53-7. PubMed ID: 3459111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice.
    Sohn MH; Jones BJ; Whiting JH; Datz FL; Lynch RE; Morton KA
    J Nucl Med; 1993 Dec; 34(12):2135-43. PubMed ID: 8254401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
    Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
    Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor and liver uptake models of 67Ga-citrate.
    Ando A; Ando I; Sanada S; Hiraki T; Hisada K
    Eur J Nucl Med; 1985; 10(5-6):262-8. PubMed ID: 3157569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.